Not recruitingISRCTN16259778
The effects of nitrous oxide (‘laughing gas’) on thoughts and feelings in healthy people
This study isn't currently recruiting.
In United KingdomSchizophreniaResearch studyAges 18–40
Schizophrenia studies
Schizophrenia
Schizophrenia can affect how a person perceives reality, thinks and feels, sometimes involving hearing voices or holding unusual beliefs.
Not recruitingISRCTN24109245
Vulnerability markers in the association between cannabis and schizophrenia
This study isn't currently recruiting.
In AustraliaSchizophreniaResearch studyAges 18+
CompletedEUCTR 2021-002572-39
Effects of add-on Celecoxib treatment in patients with schizophrenia spectrum disorders and inflammatory cytokine profile (TargetFlame)
This study has finished and is no longer accepting participants.
Historical country statuses are shown below. They describe the trial's progress and do not confirm open recruitment.
In GermanySchizophreniaHistorical research record
Not recruitingISRCTN43585723
Promoting personal recovery from psychosis: A controlled study in first episode schizophrenia
This study isn't currently recruiting.
In United KingdomSchizophreniaResearch study
Not recruitingISRCTN42505388
The London East Anglia controlled study for cognitive-behaviour therapy for psychosis: effects of the treatment phase
This study isn't currently recruiting.
In United KingdomSchizophreniaResearch study
TerminatedNCT03149107
"Multimodal Prevention of Psychosis - Investigating Efficacy of N-Acetylcysteine and Psychotherapy in CHR-Patients"
Official study title
Multimodal Prevention of First Psychotic Episode - a 2x2-Factorial Randomized Trial Investigating the Efficacy of Acetylcysteine and Integrated Preventive Psychological Intervention in Subjects Clinically at High Risk for Psychosis
This study ended early.
Multiple locations, including MannheimSchizophreniaMedication studyAges 18–40
CompletedNCT01081418
Assertive Community Treatment (ACT) in Schizophrenia Spectrum Disorders
Official study title
Assertive Community Treatment (ACT) as Part of Integrated Care Versus Standard Care: a 12-month Trial in Patients With First- and Negatively Selected Multiple-episode Schizophrenia-spectrum Disorders Treated With Quetiapine IR
This study has finished and is no longer accepting participants.
In HamburgSchizophreniaBehavioural studyAges 18–65
CompletedNCT03068806
Brain Imaging, Attention, and Auditory Processing in Schizophrenia
Official study title
Predictive Coding Abnormalities in Psychosis: EEG and fMRI
This study has finished and is no longer accepting participants.
In San FranciscoSchizophreniaObservational studyAges 18–75
CompletedNCT01876056
Brief Culturally Adapted Cognitive Behavior Therapy for Psychosis
Official study title
A Randomized Controlled Trial of Brief Culturally Adapted CBT for Schizophrenia in Pakistan
This study has finished and is no longer accepting participants.
In LahoreSchizophreniaBehavioural studyAges 18–65
Active Not RecruitingNCT04105231
Cannabidiol for Treatment of Non-affective Psychosis and Cannabis Use
This study is no longer accepting new participants.
In Glostrup MunicipalitySchizophreniaMedication studyAges 18–45
CompletedNCT01701609
Cognitive Remediation Therapy (CRT) in Adolescents With EOS
Official study title
Efficacy of a Cognitive Remediation Treatment in Adolescents With Schizophrenia Spectrum Disorders
This study has finished and is no longer accepting participants.
In BarcelonaSchizophreniaBehavioural studyAges 12–18
CompletedNCT00320671
Comparison of Aripiprazole and Risperidone for People With First-Episode Psychosis
Official study title
Preventing Morbidity in First Episode Schizophrenia, Part II
This study has finished and is no longer accepting participants.
In Glen OaksSchizophreniaMedication studyAges 15–40
Registry coverage
We gather information about mental health clinical trials from the public registries we index. Coverage is still expanding, so some studies may not appear yet.